Cefazolin sodium
Drug ingredientCAS 27164-46-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
20 FDA-registered drug labelers
A-S Medication Solutions
ACS Dobfar S.p.A
Apotex Corp.
B. Braun Medical Inc.
Baxter Healthcare Corporation
Civica, Inc.
Direct_rx
Fresenius Kabi USA, LLC
Henry Schein Inc.
Hikma Pharmaceuticals USA Inc.
Hospira, Inc
Medical Purchasing Solutions, LLC
Orchid Pharma Ltd
Proficient Rx LP
ProPharma Distribution
Qilu Antibiotics Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd.
Samson Medical Technologies, L.L.C.
Sandoz Inc
WG Critical Care, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Cefazolin
- •Cefazolin Sodium
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS27164-46-1
PubChem CID23675322
DTXSIDDTXSID901015786
FormulaC14H13N8NaO4S3
Mol. Weight476.5 g/mol
SMILESCC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)[O-].[Na+]
Data Sources
- PubChem · compound 23675322Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Cefazolin sodium (CAS 27164-46-1) https://chemicalindependence.com/chemical/27164-46-1/ PubChem: 23675322. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/23675322 FDA National Drug Code directory: CAS 27164-46-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/